Single Dose, Randomized, Two-period, Two-treatment, Two-sequence Crossover Relative Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets Under Fasting Condition.

Trial Profile

Single Dose, Randomized, Two-period, Two-treatment, Two-sequence Crossover Relative Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets Under Fasting Condition.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Jun 2011

At a glance

  • Drugs Ciprofloxacin (Primary)
  • Indications Acute sinusitis; Bacterial infections; Intestinal infections; Intra-abdominal infections; Nosocomial pneumonia; Pyelonephritis; Respiratory tract infections; Skin and soft tissue infections; Urinary tract infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 15 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top